NBRV Nabriva Therapeutics Plc Compare

benzinga

Nabriva Shares Volatile As Biopharma Updates FDA Filing Timeline

benzinga

FDA Type A Meetings: What You Need To Know

yahoo

Rosen, a Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc- NBRV

yahoo

Robbins Arroyo LLP: Nabriva Therapeutics plc Misled Shareholders According to a Recently Filed Lawsuit

yahoo

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nabriva Therapeutics plc

yahoo

NABRIVA DEADLINE ALERT: Rosen Law Firm Reminds Nabriva Therapeutics plc Investors of Important Deadline in the Securities Class Action– NBRV

yahoo

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Nabriva Therapeutics plc Investors

yahoo

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

yahoo

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Nabriva Therapeutics plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

yahoo

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nabriva Therapeutics plc – NBRV

yahoo

NABRIVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Nabriva Therapeutics plc To Contact The Firm

yahoo

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nabriva Therapeutics plc Investors

yahoo

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Nabriva Therapeutics plc Investors

yahoo

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nabriva Therapeutics plc - NBRV

benzinga

Nabriva Shares Tumble After FDA Issues CRL For Antibiotic Candidate

bizjournals

Nabriva fails to win FDA approval for experimental antibiotic

reuters

FDA declines to approve Nabriva's antibiotic for urinary tract infections

schaeffersresearch

Options Bulls Bet on This Drug Stock to Double

bizjournals

FDA's decision looming on Nabriva's experimental antibiotic

prnewswire

Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases